Down-regulation of LINC00341 Predicts a Poor Prognosis and Acts As a Tumor Suppressor in Gastric Cancer

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2020 Jan 18

PMID 31949815

Authors

Baoyu Li

Lijie He

Hui Liu

Affiliations

Soon will be listed here.

Abstract

Accumulating evidence has suggested that long noncoding RNAs (lncRNAs) play critical roles in tumor cell development and in the progression of human cancer. However, the significance and role of most lncRNAs, especially long intergenic ncRNAs (lincRNAs, the main type of lncRNAs), in gastric cancer is unclear. This study aimed to identify the clinical significance and potential biological function of LINC00341 in gastric cancer. Here, a qRT-PCR assay indicated that the relative expression level of LINC00341 were significantly down-regulated in gastric cancer tissues compared to matched adjacent normal tissues. Levels of LINC00341 in gastric cancer cell lines (MGC-803, BGC-823 and SGC-7901) were also significantly lower than in human normal gastric epithelial cell (GES-1). Patient with low LINC00341 expression were found to be negatively correlated with the TNM stage and lymph node metastasis. A Kaplan-Meier analysis showed that low expression of LINC00341 was significantly correlated with shorter overall survival (OS) of gastric cancer patients. Furthermore, an assay indicated that the over-expression of LINC00341 inhibited cell growth and migration and induced cell apoptosis in gastric cancer. In summary, this study provides the first evidence that the down-regulation of LINC00341 predicts a poor prognosis and acts as a tumor suppressor in the carcinogenesis of gastric cancer, indicating that LINC00341 may serve as a potential therapeutic target for gastric cancer.

References

Prensner J, Chinnaiyan A . The emergence of lncRNAs in cancer biology. Cancer Discov. 2011; 1(5):391-407. PMC: 3215093. DOI: 10.1158/2159-8290.CD-11-0209. View

Zhou B, Jing X, Wu J, Xi H, Lu G . Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer. Int J Clin Exp Pathol. 2015; 7(12):8893-8. PMC: 4313956. View

Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L . The incidences and mortalities of major cancers in China, 2009. Chin J Cancer. 2013; 32(3):106-12. PMC: 3845591. DOI: 10.5732/cjc.013.10018. View

Mercer T, Dinger M, Mattick J . Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10(3):155-9. DOI: 10.1038/nrg2521. View

Zhang S, Dong X, Ji T, Chen G, Shan L . Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer. Am J Transl Res. 2017; 9(2):366-375. PMC: 5340673. View

Esteller M . Non-coding RNAs in human disease. Nat Rev Genet. 2011; 12(12):861-74. DOI: 10.1038/nrg3074. View

Shi X, Sun M, Liu H, Yao Y, Song Y . Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013; 339(2):159-66. DOI: 10.1016/j.canlet.2013.06.013. View

Ponting C, Oliver P, Reik W . Evolution and functions of long noncoding RNAs. Cell. 2009; 136(4):629-41. DOI: 10.1016/j.cell.2009.02.006. View

Lai M, Yang Z, Zhou L, Zhu Q, Xie H, Zhang F . Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2011; 29(3):1810-6. DOI: 10.1007/s12032-011-0004-z. View

10.

Liao M, Li B, Zhang S, Liu Q, Liao W, Xie W . Relationship between LINC00341 expression and cancer prognosis. Oncotarget. 2017; 8(9):15283-15293. PMC: 5362486. DOI: 10.18632/oncotarget.14843. View

11.

Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M . Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol. 2014; 20(38):13842-62. PMC: 4194567. DOI: 10.3748/wjg.v20.i38.13842. View

12.

Nakajima T . Gastric cancer treatment guidelines in Japan. Gastric Cancer. 2002; 5(1):1-5. DOI: 10.1007/s101200200000. View

13.

Chen W, Huang M, Sun D, Kong R, Xu T, Xia R . Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer. Oncotarget. 2016; 7(9):9773-87. PMC: 4891083. DOI: 10.18632/oncotarget.6949. View

14.

Gan L, Xu M, Zhang Y, Zhang X, Guo W . Focusing on long noncoding RNA dysregulation in gastric cancer. Tumour Biol. 2014; 36(1):129-41. DOI: 10.1007/s13277-014-2894-9. View

15.

Chen X, Gao G, Liu S, Yu L, Yan D, Yao X . Long Noncoding RNA PVT1 as a Novel Diagnostic Biomarker and Therapeutic Target for Melanoma. Biomed Res Int. 2017; 2017:7038579. PMC: 5318621. DOI: 10.1155/2017/7038579. View

16.

Zhang Y, Yang R, Lian J, Xu H . LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer. Am J Transl Res. 2016; 8(11):5035-5043. PMC: 5126346. View

17.

Han Y, Liu Y, Zhang H, Wang T, Diao R, Jiang Z . Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. FEBS Lett. 2014; 587(23):3875-82. View

18.

Siegel R, Miller K, Jemal A . Cancer statistics, 2016. CA Cancer J Clin. 2016; 66(1):7-30. DOI: 10.3322/caac.21332. View

19.

Liu L, Liu Y, Zhuang C, Xu W, Fu X, Lv Z . Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer. Tumour Biol. 2015; 36(10):7685-9. DOI: 10.1007/s13277-015-3490-3. View

20.

Crew K, Neugut A . Epidemiology of gastric cancer. World J Gastroenterol. 2006; 12(3):354-62. PMC: 4066052. DOI: 10.3748/wjg.v12.i3.354. View